Crotedumab CAS No.1452387-69-7
Crotedumab CAS No.1452387-69-7
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-2852 | 1mg | 280.00 | + Add to cart |
|
| R-R-2852 | 2mg | 460.00 | + Add to cart |
|
|
|
||||
Product description
Crotedumab (REGN1193)/CAS No.1452387-69-7 is a fully human IgG4 monoclonal antibody that binds and inhibits glucagon receptor (GCGR), with a KD of 0.1 nM. Crotedumab can be used for the research of diabetes.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Purity | >90% |
| CAS | 1452387-69-7 |
| Synonyms | REGN1193; Anti-GCGR Reference Antibody (crotedumab) |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Crotedumab CAS No.1452387-69-7
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


